Drugs, healthcare services and medical devices continue to remain the most fundamental need of humans as well as any other living creatures that may have access to them. The larger healthcare industry, which is now estimated to be worth around $300 trillion, serves this basic requirement. Hundreds of healthcare companies have listed their stocks for active trading on the leading stock exchanges across the globe. It allows a convenient channel to short term traders as well as long term investors to take a shot at the performance of such healthcare companies with an aim to generate profits. Among the several healthcare companies whose stocks are listed and actively trading on the stock exchanges, which have been the winners in terms of highest returns? This article provides a list of healthcare stocks that have given the top returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual healthcare stocks between the end of the previous and Apr 16, 2021, and the top 10 return generating healthcare stocks are listed below.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Healthcare sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) KemPharm, Inc. (KMPH)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of KemPharm. The Iowa, IA-headquartered company KemPharm, Inc. (KMPH) is ranked number one among the best performing stocks of Healthcare of 2021. The Health Care sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2021, the stock price of KemPharm has changed by 1094.44 percent, which is calculated based on the previous year's closing price of $0.72 per share and year-to-date closing price of $8.6 per share as of writing. The market value of the company as indicated by its market-cap changed from $3.27 million to $244.04 million during the same period. Along with Healthcare, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Biotech, Wilshire 5000, among other usual products and services. KemPharm continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
TransEnterix, Inc., incorporated in August 19, 1988, is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), a ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of TransEnterix. Based on the market-cap change from $62.44 million to $916.88 million during the given months of the year 2021 and the share price change from $0.63 per share to a price of $4.08 per share as of Apr 16, 2021, TransEnterix, Inc. (TRXC) was successful in generating YTD returns of 552.8 percentage. Standing at the number two rank in the top performing list of Healthcare stocks, the North Carolina, NC-based TransEnterix is categorized as the Medical Dental Instruments sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, and a few more broader-level indexes that are actively tracked in the market.
Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Acorda Therapeutics. During the given months of the year 2021, Acorda Therapeutics, Inc. (ACOR) was successful in generating YTD returns of 507.16 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the New York, NY-based Acorda Therapeutics closed at a price of $0.69 per share, while it traded at a price of $4.19 per share as of Apr 16, 2021. The company's market cap changed from $39.25 million to $39.76 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators.
The company is classified under the Health Care industry sector and further specialized as a Biotech Biological Products sector business.
Guardion Health Sciences
Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device t ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Guardion Health Sciences. The San Diego, CA-based Healthcare sector company Guardion Health Sciences, Inc. (GHSI) holds the number four spot among the best performing stocks of the Healthcare sector. Classified as the Drug Manufacturer business, the stock price of Guardion Health Sciences ended the previous year at a price of $0.42 per share while it reached the level of $1.84 apiece as of Apr 16, 2021 translating to a percentage change in stock price of 343.37%. As of writing, the company's market-cap value stands at $44.95 million.
Moleculin Biotech, Inc., incorporated on July 28, 2015, is a preclinical and clinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. The Companys lead drug ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Moleculin Biotech. Rank number five in the coveted list is held by Moleculin Biotech, Inc. (MBRX) for being among the top performing stocks of 2021. Headquartered in Texas, TX, the Health Care sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2021, stock of Moleculin Biotech has so far gained 331.56 percentage, based on the previous year's closing price of $0.8 per share and year-to-date price of $3.44 per share. During the same period, the market capitalization of the company changed from $49.79 million to $103.25 million.
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Aclaris Therapeutics. At number six in the list of top stocks stands Aclaris Therapeutics, Inc. (ACRS), which saw a change in its stock price from the level of $6.47 apiece during previous year December end to the price of $26.68 per share as of Apr 16, 2021. It translates to a change of 312.36 percentage. The Pennsylvania, PA-headquartered Health Care sector company also saw its market value change from $277.69 million to $1.38 billion. The Major Pharmaceuticals specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.
Pandion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing various therapeutics to address the unmet needs of patients ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Pandion Therapeutics. Pandion Therapeutics, Inc. (PAND) has moved by 304.38 percentage over the given period of 2021-YTD, helping it gain a place at number seven among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $14.85 apiece to the price of $60.05 per share between the end of December of the previous year and Apr 16, 2021. The smart run of the Watertown, Massachusetts-based Biotechnology sector company lead to a handsome gain in its marketcap which changed from $438.37 million to $1.77 billion over the same duration.
Second Sight Medical Products
Second Sight Medical Products, Inc., incorporated on May 22, 2003, is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Companys product, the Argus ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Second Sight Medical Products. The California, CA-based Second Sight Medical Products, Inc. (EYES) belongs to the Health Care sector and is categorized as a Biotech-Electromedical Electrotherapeutic Apparatus company. The stock of Second Sight Medical Products ended the previous year at a price of $1.87 per share. As of Apr 16, 2021, the stock price has reached $7.36 apiece, which indicates a change of 293.58 percent making the company rank among the top performing stocks of the Healthcare for the year 2021 till date. At the end of the last year, company's market capitalization stood at $43.23 million. It has now changed to $205.35 million as of writing. Second Sight Medical Products continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.
China Sxt Pharma
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of China Sxt Pharma. China Sxt Pharma (SXTC) generated percentage returns of 292.46 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $0.33 per share from the previous year-end to the price of $1.29 per share as of Apr 16, 2021. The company's value, as indicated by the market-cap figure, changed from $24.34 million to $20.01 million during the same period. The company is categorized as a Healthcare speciality business with further classification in the Drug Manufacturer sub-category. Based in Taizhou, , the YTD performance of the Healthcare sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Zomedica Pharmaceuticals. The number ten spot in the list of top performing stocks of the Healthcare sector is taken by Zomedica Pharmaceuticals Corp. (ZOM). The company's stock price changed from $0.23 per share at the end of December of the previous year to the price of $0.85 per share as of writing. Overall, the stock managed to realized price change of 268.6 percent during the given time period. The corresponding change in the market capitalization value of the USA-based Health Care sector company was from $130.07 million to $826.21 million. Being ranked in the top 10 best performing stocks of the Healthcare sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.